← All stories
Markets
STAT+: A Novartis drug cut inflammation. Can it improve heart outcomes?
A newly acquired Novartis drug cut signs of inflammation. The test will be whether that can improve people's heart health.
Covered by 1 outlet
All coverage · 1 article